RT Journal Article
SR Electronic
T1 Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008837
DO 10.1136/jitc-2024-008837
VO 12
IS 7
A1 Ghosh, Chandra C
A1 Cournoyer, Lauren
A1 Liu, Yujia
A1 Ballarin, Alizee
A1 Layman, Ilan B
A1 LaPorte, Jason
A1 Morrissey, Molly
A1 Fraser, Kayla
A1 Perati, Shriya
A1 Cox, Bryan F
A1 Yakirevich, Evgeny
A1 Treaba, Diana O
A1 Murtha, Timothy D
A1 Guha, Prajna
A1 Katz, Steven C
A1 Davar, Diwakar
YR 2024
UL http://jitc.bmj.com/content/12/7/e008837.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.